Crossref journal-article
Elsevier BV
Advanced Drug Delivery Reviews (78)
Bibliography

Schinkel, A. H. (1999). P-Glycoprotein, a gatekeeper in the blood–brain barrier. Advanced Drug Delivery Reviews, 36(2–3), 179–194.

Authors 1
  1. Alfred H Schinkel (first)
References 79 Referenced 788
  1. M. Naito, T. Tsuruo, Role of P-glycoprotein in the blood–brain barrier. In: S. Gupta, T. Tsuruo (Eds.), Multidrug Resistance in Cancer Cells, John Wiley and Sons, Ltd., Chichester, 1996, pp. 321–333.
  2. 10.1016/S0169-409X(97)00504-8 / Adv. Drug Deliv. Rev. / Blood–brain barrier function of P-glycoprotein by Tsuji (1997)
  3. 10.1146/annurev.bi.58.070189.001033 / Annu. Rev. Biochem. / The biochemistry of P-glycoprotein-mediated multidrug resistance by Endicott (1989)
  4. 10.1016/0006-2952(92)90666-7 / Biochem. Pharmacol. / The role of the MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo by Roninson (1992)
  5. 10.1146/annurev.bi.62.070193.002125 / Annu. Rev. Biochem. / Biochemistry of multidrug resistance mediated by the multidrug transporter by Gottesman (1993)
  6. 10.1016/0165-6147(94)90322-0 / Trends Pharmacol. Sci. / A mechanism for P-glycoprotein action in multidrug resistance: are we there yet? by Ruetz (1994)
  7. 10.1016/S0168-9525(97)01112-8 / Trends Genet. / Genetic dissection of the function of mammalian P-glycoproteins by Borst (1997)
  8. {'key': '10.1016/S0169-409X(98)00085-4_BIB8', 'first-page': '1', 'article-title': 'Enhanced transepithelial flux of cimetidine by Madin–Darby canine kidney cells overexpressing human P-glycoprotein', 'volume': '270', 'author': 'Pan', 'year': '1994', 'journal-title': 'J. Pharmacol. Exp. Ther.'} / J. Pharmacol. Exp. Ther. / Enhanced transepithelial flux of cimetidine by Madin–Darby canine kidney cells overexpressing human P-glycoprotein by Pan (1994)
  9. 10.1016/S0092-8674(00)81370-7 / Cell / MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine by Van Helvoort (1996)
  10. 10.1073/pnas.93.3.1238 / Proc. Natl. Acad. Sci. USA / P-glycoprotein confers methotrexate resistance in 3T6 cells with deficient carrier-mediated methotrexate uptake by De Graaf (1996)
  11. 10.1016/0968-0004(92)90419-A / Trends Biochem. Sci. / Is the multidrug transporter a flippase? by Higgins (1992)
  12. {'key': '10.1016/S0169-409X(98)00085-4_BIB12', 'first-page': '1967', 'article-title': 'Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil', 'volume': '41', 'author': 'Tsuruo', 'year': '1981', 'journal-title': 'Cancer Res.'} / Cancer Res. / Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil by Tsuruo (1981)
  13. 10.1016/S0889-8588(18)30099-6 / Hematol. Oncol. Clin. North Am. / Clinical studies with modulators of multidrug resistance by Fisher (1995)
  14. {'key': '10.1016/S0169-409X(98)00085-4_BIB14', 'first-page': '67', 'article-title': 'Clinical reversal of drug resistance', 'volume': 'XIX', 'author': 'Goldstein', 'year': '1995', 'journal-title': 'Curr. Probl. Cancer'} / Curr. Probl. Cancer / Clinical reversal of drug resistance by Goldstein (1995)
  15. {'key': '10.1016/S0169-409X(98)00085-4_BIB15', 'first-page': '4595', 'article-title': 'In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative', 'volume': '53', 'author': 'Hyafil', 'year': '1993', 'journal-title': 'Cancer Res.'} / Cancer Res. / In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative by Hyafil (1993)
  16. {'key': '10.1016/S0169-409X(98)00085-4_BIB16', 'first-page': '7', 'article-title': 'Flow cytometric assay of modulation of P-glycoprotein function in whole blood by the multidrug resistance inhibitor GG918', 'volume': '2', 'author': 'Witherspoon', 'year': '1996', 'journal-title': 'Clin. Cancer Res.'} / Clin. Cancer Res. / Flow cytometric assay of modulation of P-glycoprotein function in whole blood by the multidrug resistance inhibitor GG918 by Witherspoon (1996)
  17. {'key': '10.1016/S0169-409X(98)00085-4_BIB17', 'first-page': '4171', 'article-title': 'Reversal of P-glycoprotein-mediated resistance by a potent cyclopropyldibenzosuberane modulator, LY335979', 'volume': '56', 'author': 'Dantzig', 'year': '1996', 'journal-title': 'Cancer Res.'} / Cancer Res. / Reversal of P-glycoprotein-mediated resistance by a potent cyclopropyldibenzosuberane modulator, LY335979 by Dantzig (1996)
  18. 10.1073/pnas.84.21.7735 / Proc. Natl. Acad. Sci. USA / Cellular localization of the multidrug resistance gene product in normal human tissues by Thiebaut (1987)
  19. 10.1128/MCB.9.3.1346 / Mol. Cell. Biol. / The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues by Croop (1989)
  20. 10.1073/pnas.85.12.4350 / Proc. Natl. Acad. Sci. USA / The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus by Arceci (1988)
  21. 10.1016/S0021-9258(18)80173-9 / J. Biol. Chem. / Differential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cells by Hsu (1989)
  22. 10.1128/MCB.10.4.1652 / Mol. Cell. Biol. / Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities by Devault (1990)
  23. 10.1016/0092-8674(94)90212-7 / Cell / Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood–brain barrier and to increased sensitivity to drugs by Schinkel (1994)
  24. 10.1073/pnas.94.8.4028 / Proc. Natl. Acad. Sci. USA / Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins by Schinkel (1997)
  25. 10.1073/pnas.94.5.2031 / Proc. Natl. Acad. Sci. USA / Limited oral bio-availability and active epithelial excretion of paclitaxel (taxol) caused by P-glycoprotein in the intestine by Sparreboom (1997)
  26. 10.1038/bjc.1997.530 / Br. J. Cancer / Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833 by Van Asperen (1997)
  27. 10.1093/jnci/88.14.994 / J. Natl. Cancer Inst. / Altered pharmacokinetics of vinblastine in mdr1a P-glycoprotein deficient mice by Van Asperen (1996)
  28. 10.1111/j.1476-5381.1996.tb15775.x / Br. J. Pharmacol. / Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr1a P-glycoprotein by Mayer (1996)
  29. 10.1172/JCI119784 / J. Clin. Invest. / Full blockade of intestinal P-glycoprotein and extensive inhibition of blood–brain barrier P-glycoprotein by oral treatment of mice with PSC833 by Mayer (1997)
  30. 10.1002/hep.510270422 / Hepatology / Contribution of the murine mdr1a P-glycoprotein to hepatobiliary and intestinal elimination of cationic drugs as measured in mice with a mdr1a gene disruption by Smit (1998)
  31. 10.1038/scientificamerican0986-74 / Sci. Am. / The blood–brain barrier by Goldstein (1986)
  32. 10.1146/annurev.pa.28.040188.000325 / Ann. Rev. Pharmacol. Toxicol. / Recent advances in blood–brain barrier transport by Pardridge (1988)
  33. 10.1113/expphysiol.1993.sp003698 / Exp. Phys. / The blood–brain barrier by Bradbury (1993)
  34. 10.1161/01.RES.57.2.213 / Circulation Res. / The blood–brain barrier by Bradbury (1985)
  35. 10.1021/jm00180a022 / J. Med. Chem. / Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability by Levin (1980)
  36. 10.1073/pnas.86.2.695 / Proc. Natl. Acad. Sci. USA / Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood–brain barrier sites by Cordon-Cardo (1989)
  37. 10.1177/37.2.2463300 / J. Histochem. Cytochem. / Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: Evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein by Thiebaut (1989)
  38. 10.1093/oxfordjournals.annonc.a057676 / Ann. Oncol. / Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues by Van der Valk (1990)
  39. 10.1111/j.1349-7006.1990.tb02636.x / Jpn. J. Cancer Res. / Specialized localization of P-glycoprotein recognized by MRK16 monoclonal antibody in endothelial cells of the brain and the spinal cord by Sugawara (1990)
  40. 10.1007/BF00230349 / Virchows Arch. / Ultrastructural localization of P-glycoprotein on capillary endothelial cells in human gliomas by Tanaka (1994)
  41. {'key': '10.1016/S0169-409X(98)00085-4_BIB41', 'first-page': '853', 'article-title': 'MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors', 'volume': '149', 'author': 'Tóth', 'year': '1996', 'journal-title': 'Am. J. Pathol.'} / Am. J. Pathol. / MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors by Tóth (1996)
  42. J.B.M.M. Van Bree, A.G. de Boer, M. Danhof, D.D. Breimer, Drug transport across the blood–brain barrier. In: J.B.M.M. van Bree (Ed.), Drug Transport Across the Blood–Brain Barrier, PhD Thesis, University of Leiden, All In BV, Katwijk, 1990, pp. 8–62. (10.1016/0168-3659(90)90008-H)
  43. {'key': '10.1016/S0169-409X(98)00085-4_BIB43', 'first-page': '545', 'article-title': 'Expression and functions of P-glycoprotein (mdr1 gene product) in normal and malignant tissues', 'volume': '40', 'author': 'Sugawara', 'year': '1990', 'journal-title': 'Acta Pathol. Jpn.'} / Acta Pathol. Jpn. / Expression and functions of P-glycoprotein (mdr1 gene product) in normal and malignant tissues by Sugawara (1990)
  44. 10.1016/0024-3205(92)90537-Y / Life Sci. / P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells by Tsuji (1992)
  45. 10.1177/44.7.8675989 / J. Histochem. Cytochem. / Cellular localization of P-glycoprotein in brain versus gonadal capillaries by Stewart (1996)
  46. 10.1016/0006-2952(95)02073-X / Biochem. Pharmacol. / Interaction of drugs with P-glycoprotein in brain capillaries by Jetté (1995)
  47. 10.1111/j.1365-2141.1990.tb07876.x / Br. J. Haematol. / Expression of the multiple drug resistance gene (mdr-1) and epitope masking in chronic lymphatic leukaemia by Cumber (1990)
  48. J.P. O'Brien, C. Cordon-Cardo, P-glycoprotein expression in normal human tissues. In: S. Gupta, T. Tsuruo (Eds.), Multidrug Resistance in Cancer Cells, John Wiley and Sons, Ltd., Chichester, 1996, pp. 285–291.
  49. 10.1177/39.12.1682363 / J. Histochem. Cytochem. / Some monoclonal antibody reagents (C219 and JSB-1) to P-glycoprotein contain antibodies to blood group A carbohydrate determinants: a problem of quality control for immunohistochemical analysis by Finstad (1991)
  50. 10.1042/bj3260539 / Biochem. J. / P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain by Beaulieu (1997)
  51. 10.1111/j.1528-1157.1995.tb01657.x / Epilepsia / MDR1 gene expression in brain of patients with medically intractable epilepsy by Tishler (1995)
  52. 10.1046/j.1471-4159.1997.68031278.x / J. Neurochem. / Brain microvascular and astrocyte localization of P-glycoprotein by Pardridge (1997)
  53. 10.1016/S0021-9258(19)88713-6 / J. Biol. Chem. / Functional involvement of P-glycoprotein in blood–brain barrier by Tatsuta (1992)
  54. 10.1016/0006-2952(93)90677-O / Biochem. Pharmacol. / Restricted transport of cyclosporin A across the blood–brain by a multidrug transporter. P-glycoprotein by Tsuji (1993)
  55. {'key': '10.1016/S0169-409X(98)00085-4_BIB55', 'first-page': '6969', 'article-title': 'Expression and functional activity of P-glycoprotein in cultured cerebral capillary endothelial cells', 'volume': '52', 'author': 'Hegmann', 'year': '1992', 'journal-title': 'Cancer Res.'} / Cancer Res. / Expression and functional activity of P-glycoprotein in cultured cerebral capillary endothelial cells by Hegmann (1992)
  56. 10.1042/bj3050761 / Biochem. J. / Isoform I (mdr3) is the major form of P-glycoprotein expressed in mouse brain capillaries. Evidence for cross-reactivity of antibody C219 with an unrelated protein by Jetté (1995)
  57. 10.1016/0014-5793(95)01104-M / FEBS Lett. / Comparisons of P-glycoprotein expression in isolated rat brain microvessels and in primary cultures of endothelial cells derived from microvasculature of rat brain, epididymal fat pad and from aorta by Barrand (1995)
  58. 10.1016/0006-8993(95)00511-N / Brain Res. / Isolation and culture of human brain microvessel endothelial cells for the study of blood–brain barrier properties in vitro by Biegel (1995)
  59. 10.1016/0167-4889(94)90047-7 / Biochim. Biophys. Acta / Transport of cyclosporin A across the brain capillary endothelial cell monolayer by P-glycoprotein by Shirai (1994)
  60. 10.1172/JCI118214 / J. Clin. Invest. / Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A by Schinkel (1995)
  61. 10.1006/taap.1996.8086 / Toxicol. Appl. Pharmacol. / P-glycoprotein deficiency in a subpopulation of CF-1 mice enhances avermectin-induced neurotoxicity by Lankas (1997)
  62. 10.1006/taap.1997.8225 / Toxicol. Appl. Pharmacol. / Identification of a P-glycoprotein-deficient subpopulation in the CF-1 mouse strain using a restriction fragment length polymorphism by Umbenhauer (1997)
  63. {'key': '10.1016/S0169-409X(98)00085-4_BIB63', 'first-page': '33', 'article-title': 'Investigating ivermectin hypersensitivity in collies', 'volume': '80', 'author': 'Pulliam', 'year': '1985', 'journal-title': 'Vet. Med.'} / Vet. Med. / Investigating ivermectin hypersensitivity in collies by Pulliam (1985)
  64. 10.1172/JCI118699 / J. Clin. Invest. / P-glycoprotein in the blood–brain barrier of mice influences the brain penetration and pharmacological activity of many drugs by Schinkel (1996)
  65. 10.1172/JCI1269 / J. Clin. Invest. / The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors by Kim (1998)
  66. 10.1172/JCI2575 / J. Clin. Invest. / HIV-1 protease inhibitors and the MDR1 multidrug transporter by Lee (1998)
  67. {'key': '10.1016/S0169-409X(98)00085-4_BIB67', 'first-page': '1226', 'article-title': 'Multidrug resistance-reversing agents increase vinblastine distribution in normal tissues expressing the P-glycoprotein but do not enhance drug penetration in brain and testis', 'volume': '281', 'author': 'Arboix', 'year': '1997', 'journal-title': 'J. Pharmacol. Exp. Ther.'} / J. Pharmacol. Exp. Ther. / Multidrug resistance-reversing agents increase vinblastine distribution in normal tissues expressing the P-glycoprotein but do not enhance drug penetration in brain and testis by Arboix (1997)
  68. 10.1016/0006-2952(94)90601-7 / Biochem. Pharmacol. / In vivo evidence for ATP-dependent and P-glycoprotein-mediated transport of cyclosporin A at the blood–brain barrier by Sakata (1994)
  69. 10.1006/bbrc.1995.1872 / Biochem. Biophys. Res. Comm. / Effect of the P-glycoprotein inhibitor, cyclosporin A, on the distribution of rhodamine-123 to the brain: an in vivo microdialysis study in freely moving rats by Wang (1995)
  70. {'key': '10.1016/S0169-409X(98)00085-4_BIB70', 'first-page': '298', 'article-title': 'The effect of verapamil on the transport of peptides across the blood brain barrier in rats: kinetic evidence for an apically polarized efflux mechanism', 'volume': '273', 'author': 'Chikhale', 'year': '1995', 'journal-title': 'J. Pharmacol. Exp. Ther.'} / J. Pharmacol. Exp. Ther. / The effect of verapamil on the transport of peptides across the blood brain barrier in rats: kinetic evidence for an apically polarized efflux mechanism by Chikhale (1995)
  71. 10.1007/s002800050515 / Cancer Chemother. Pharmacol. / Dose-dependent brain penetration of SDZ PSC 833, a novel multidrug resistance-reversing cyclosporin, in rats by Lemaire (1996)
  72. 10.1046/j.1471-4159.1996.67041688.x / J. Neurochem. / Role of P-glycoprotein in the blood–brain transport of colchicine and vinblastine by Drion (1996)
  73. 10.1016/S0024-3205(97)00370-6 / Life Sci. / Effect of the P-glycoprotein inhibitor, SDZ PSC 833, on the blood and brain pharmacokinetics of colchicine by Desrayaud (1997)
  74. 10.1002/(SICI)1097-4547(19970701)49:1<80::AID-JNR9>3.0.CO;2-9 / J. Neurosci. Res. / Role of P-170 P-glycoprotein in colchicine brain uptake by Drion (1997)
  75. 10.1002/ijc.2910630220 / Int. J. Cancer / Decreased biotolerability for ivermectin and cyclosporin A in mice exposed to potent P-glycoprotein inhibitors by Didier (1995)
  76. 10.1073/pnas.91.1.68 / Proc. Natl. Acad. Sci. USA / A method to determine the ability of drugs to diffuse through the blood–brain barrier by Seelig (1994)
  77. {'key': '10.1016/S0169-409X(98)00085-4_BIB77', 'first-page': '681', 'article-title': 'Structure-activity relationship studies on modulators of the multidrug transporter P-glycoportein-an overview', 'volume': '107', 'author': 'Ecker', 'year': '1995', 'journal-title': 'Wien. Klin. Wochenschr.'} / Wien. Klin. Wochenschr. / Structure-activity relationship studies on modulators of the multidrug transporter P-glycoportein-an overview by Ecker (1995)
  78. 10.1021/js9701364 / J. Pharm. Sci. / The functional role of P-glycoprotein in the blood–brain barrier by Van Asperen (1997)
  79. 10.1006/abbi.1997.0537 / Arch. Biochem. Biophys. / Human MDR1 and mouse mdr1a P-glycoprotein alter the cellular retention and disposition of erythromycin, but not retinoic acid or benzo(a)pyrene by Schuetz (1998)
Dates
Type When
Created 23 years ago (July 25, 2002, 10:54 p.m.)
Deposited 4 years, 3 months ago (May 14, 2021, 11:11 a.m.)
Indexed 4 days, 19 hours ago (Aug. 19, 2025, 6:08 a.m.)
Issued 26 years, 4 months ago (April 1, 1999)
Published 26 years, 4 months ago (April 1, 1999)
Published Print 26 years, 4 months ago (April 1, 1999)
Funders 0

None

@article{Schinkel_1999, title={P-Glycoprotein, a gatekeeper in the blood–brain barrier}, volume={36}, ISSN={0169-409X}, url={http://dx.doi.org/10.1016/s0169-409x(98)00085-4}, DOI={10.1016/s0169-409x(98)00085-4}, number={2–3}, journal={Advanced Drug Delivery Reviews}, publisher={Elsevier BV}, author={Schinkel, Alfred H}, year={1999}, month=apr, pages={179–194} }